GGrantIndex
Sort

78,016 grants matching breast cancer

Molecular Analysis of Breast Cancer Metastasis to the Brain

$725,886
Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Metabolic Effects of Thyroid Hormone

$725,852
Herbert H Samuels · New York University School Of Medicine · R01 · FY2007 · DK

Moffitt Imaging Biomarker VAlidation Center

$725,817
John J Heine · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2018 · CA

Descriptive Studies and Record Linkage

$725,750
William Anderson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

3D Bioprinted lung cancer models for drug screening

$725,727
Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR

Breast and Ovary Cancer Clinical Validation Center

$725,717
Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA

Yoga for women with breast cancer undergoing radiotherapy

$725,391
Lorenzo Cohen · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

Telomeres and lung cancer incidence and survival

$725,296
Jennifer A. Doherty · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA

Exercise as Interception Therapy in Primary High Risk Cancer

$725,188
Lee W Jones · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Functional Analysis of Breast Cancer Susceptibility Genes in Mice

$725,148
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Reducing risk of Anthracycline-related heart failure after childhood cancer

$725,110
Saro Armenian · Beckman Research Institute/City Of Hope · R01 · FY2015 · CA

Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function

$724,846
Satchidananda Panda · Salk Institute For Biological Studies · R01 · FY2022 · CA

Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function

$724,846
Satchidananda Panda · Salk Institute For Biological Studies · R01 · FY2023 · CA

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma

$724,798
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Novel Therapeutic Targets for Venous Thromboembolism

$724,778
Thomas William Wakefield · University Of Michigan At Ann Arbor · R01 · FY2010 · HL

LncRNA mechanisms in cancer

$724,705
Howard Y Chang · Stanford University · R35 · FY2016 · CA

Older Breast Cancer Patients: Risk For Cognitive Decline

$724,682
Jeanne Mandelblatt · Georgetown University · R01 · FY2018 · CA

STIMULTANEOUS VASCULAR TARGETING AND TUMOR TARGETING OF CEREBRAL BREAST CANCER

$724,610
Texas Tech University Health Sciences Center · · FY2012 · Department of Defense

Genomic and Translational Approaches to Neuroendocrine Switching Events

$724,605
Michael G Rosenfeld · University Of California, San Diego · R37 · FY2011 · DK

Molecular signatures for liver cancer diagnosis and treatment stratification

$724,589
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Activating Cell Death Pathways in Breast Cancer Cells

$724,562
Stanley Lipkowitz · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA

DCTD Cancer Diagnosis

$724,542
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA

TARGETING DORMANCY-ASSOCIATED IMMUNE TOLERANCE TO ELIMINATE RESIDUAL BREAST CANCER

$724,500
Duke University · · FY2025 · Defense Health Agency

Integrated analyses of genetics, epigenetics, and gene expression

$724,403
Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2019 · CA

RISK OF CANCER IN A-T FAMILIES

$724,352
University Of Southern California · U01 · FY2001 · CA